Qube Research & Technologies LTD Silence Therapeutics PLC Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 18,913 shares of SLN stock, worth $104,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,913
Previous 54,746
65.45%
Holding current value
$104,399
Previous $376,000
85.9%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$16.7 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.79MShares$15.4 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$12.2 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$11 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$10.2 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $198M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...